Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Prostate Cancer

Free Subscription Articles published in J Urol Retrieve available abstracts of 235 articles: HTML format Text format

Single Articles

February 2010
1. LOWRANCE WT , Elkin EB, Jacks LM, Yee DS, et al
   Comparative Effectiveness of Prostate Cancer Surgical Treatments: A Population Based Analysis of Postoperative Outcomes.
   J Urol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. LLOYD JC , Antonelli JA, Phillips TE, Masko EM, et al
   Effect of Isocaloric Low Fat Diet on Prostate Cancer Xenograft Progression in a Hormone Deprivation Model.
   J Urol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. CHANG G , Xu S, Watanabe M, Jayakar HR, et al
   Enhanced Oncolytic Activity of Vesicular Stomatitis Virus Encoding SV5-F Protein Against Prostate Cancer.
   J Urol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. D'ANTONIO KB , Toubaji A, Albadine R, Mondul AM, et al
   Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development.
   J Urol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. LE BV , Griffin CR, Loeb S, Carvalhal GF, et al
   [-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study.
   J Urol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. WALSH PC
   Urological oncology: prostate cancer.
   J Urol. 2010;183:552-5.
   PubMed     Text format     Related articles   
   
   
   
7. PINKAWA M
   Editorial comment.
   J Urol. 2010;183:639.
   PubMed     Text format     Related articles   
   
   
   
8. WILLIAMS SG
   Editorial comment.
   J Urol. 2010;183:639.
   PubMed     Text format     Related articles   
   
   
   
9. STONE NN , Marshall DT, Stone JJ, Cesaretti JA, et al
   Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?
   J Urol. 2010;183:634-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. KIBEL AS
    Editorial comment.
    J Urol. 2010;183:533.
    PubMed     Text format     Related articles   
    
    
    
11. PLOUSSARD G , Salomon L, Xylinas E, Allory Y, et al
    Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?
    J Urol. 2010;183:539-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. SCHILLING D , Stenzl A
    Editorial comment.
    J Urol. 2010;183:527-8.
    PubMed     Text format     Related articles   
    
    
    
13. TOSOIAN JJ , Loeb S, Kettermann A, Landis P, et al
    Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program.
    J Urol. 2010;183:534-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. EPSTEIN JI
    An update of the Gleason grading system.
    J Urol. 2010;183:433-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. SUARDI N
    Editorial comment.
    J Urol. 2010;183:545.
    PubMed     Text format     Related articles   
    
    
    
16. HAMBROCK T , Somford DM, Hoeks C, Bouwense SA, et al
    Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
    J Urol. 2010;183:520-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ROACH M 3RD
    Editorial comment.
    J Urol. 2010;183:551.
    PubMed     Text format     Related articles   
    
    
    January 2010
18. SCHELLHAMMER PF
    Re: Chemoprevention of Prostate Cancer I. M. Thompson, C. M. Tangen, P. J. Goodman, M. S. Lucia and E. A. KleinJ Urol 2009; 182: 499-508.
    J Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
19. WATSON RA
    Re: Prostate Cancer Severity Among Low Income, Uninsured Men D. C. Miller, M. S. Litwin, J. Bergman, S. Stepanian, S. E. Connor, L. Kwan and W. J. AronsonJ Urol 2009; 181: 579-584.
    J Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
20. AHIRWAR DK , Mittal RD
    Re: Genetic Polymorphisms of Matrix Metalloproteinases: Susceptibility and Prognostic Implications for Prostate Cancer S. T. dos Reis, J. Pontes, Jr., F. E. Villanova, P. M. D. Borra, A. A. Antunes, M. F. Dall'oglio, M. Srougi and K. R. M. LeiteJ Urol
    J Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
21. STOPIGLIA RM , Ferreira U, Silva MM Jr, Matheus WE, et al
    Prostate Specific Antigen Decrease and Prostate Cancer Diagnosis: Antibiotic Versus Placebo Prospective Randomized Clinical Trial.
    J Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. TANG P , Sun L, Uhlman MA, Robertson CN, et al
    Initial Prostate Specific Antigen 1.5 ng/ml or Greater in Men 50 Years Old or Younger Predicts Higher Prostate Cancer Risk.
    J Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. BAROCAS DA , Salem S, Kordan Y, Herrell SD, et al
    Robotic Assisted Laparoscopic Prostatectomy Versus Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer: Comparison of Short-Term Biochemical Recurrence-Free Survival.
    J Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
24. NGUYEN CT , Yu C, Moussa A, Kattan MW, et al
    Performance of Prostate Cancer Prevention Trial Risk Calculator in a Contemporary Cohort Screened for Prostate Cancer and Diagnosed by Extended Prostate Biopsy.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. STOCK RG , Yamalachi S, Hall SJ, Stone NN, et al
    Impact of Hormonal Therapy on Intermediate Risk Prostate Cancer Treated With Combination Brachytherapy and External Beam Irradiation.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
26. ARONSON WJ , Barnard RJ, Freedland SJ, Henning S, et al
    Growth Inhibitory Effect of Low Fat Diet on Prostate Cancer Cells: Results of a Prospective, Randomized Dietary Intervention Trial in Men With Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. LOEB S , Roehl KA, Helfand BT, Kan D, et al
    Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection?
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. MAGHELI A , Hinz S, Hege C, Stephan C, et al
    Prostate Specific Antigen Density to Predict Prostate Cancer Upgrading in a Contemporary Radical Prostatectomy Series: A Single Center Experience.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. EANDI JA , Link BA, Nelson RA, Josephson DY, et al
    Robotic Assisted Laparoscopic Salvage Prostatectomy for Radiation Resistant Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. YU JB , Makarov DV, Sharma R, Peschel RE, et al
    Validation of the Partin Nomogram for Prostate Cancer in a National Sample.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
31. KESARWANI P , Mandhani A, Mittal RD
    Polymorphisms in Tumor Necrosis Factor-A Gene and Prostate Cancer Risk in North Indian Cohort.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. WHEAT JC , Hedgepeth RC, He C, Zhang L, et al
    Clinical Interpretation of the Expanded Prostate Cancer Index Composite-Short Form Sexual Summary Score.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. LAWRENTSCHUK N , Toi A, Lockwood GA, Evans A, et al
    Operator is an Independent Predictor of Detecting Prostate Cancer at Transrectal Ultrasound Guided Prostate Biopsy.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. EYRE SJ , Ankerst DP, Wei JT, Nair PV, et al
    Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SMITH MR , Saad F, Egerdie B, Szwedowski M, et al
    Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. WRIGHT JL , Salinas CA, Lin DW, Kolb S, et al
    Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. KLOTZ L
    Active Surveillance for Favorable Risk Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles   
    
    
    
38. FUJITA K , Landis P, McNeil BK, Pavlovich CP, et al
    Serial Prostate Biopsies are Associated With an Increased Risk of Erectile Dysfunction in Men With Prostate Cancer on Active Surveillance.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. HALTER RJ , Schned A, Heaney J, Hartov A, et al
    Electrical properties of prostatic tissues: I. Single frequency admittivity properties.
    J Urol. 2009;182:1600-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. HALTER RJ , Schned A, Heaney J, Hartov A, et al
    Electrical properties of prostatic tissues: II. Spectral admittivity properties.
    J Urol. 2009;182:1608-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. AKAN H
    Editorial comment.
    J Urol. 2009;182:1335.
    PubMed     Text format     Related articles   
    
    
    
42. PLOUSSARD G , Dubosq F, Boublil V, Allory Y, et al
    Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
    J Urol. 2009;182:1342-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. PFITZENMAIER J
    Editorial comment.
    J Urol. 2009;182:1363.
    PubMed     Text format     Related articles   
    
    
    
44. DAMODARAN C
    Editorial comment.
    J Urol. 2009;182:1356.
    PubMed     Text format     Related articles   
    
    
    
45. GOMEZ CS , Gomez P, Knapp J, Jorda M, et al
    Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.
    J Urol. 2009;182:1350-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. TROCK BJ , Guo CC, Gonzalgo ML, Magheli A, et al
    Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.
    J Urol. 2009;182:1364-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. NIELSEN ME
    How bad are positive margins after radical prostatectomy and how are they best managed?
    J Urol. 2009;182:1257-8.
    PubMed     Text format     Related articles   
    
    
    
48. CHONG KT
    Editorial comment.
    J Urol. 2009;182:1348.
    PubMed     Text format     Related articles   
    
    
    
49. PARSONS JK
    Editorial comment.
    J Urol. 2009;182:1340-1.
    PubMed     Text format     Related articles   
    
    
    
50. MERSEBURGER AS
    Editorial comment.
    J Urol. 2009;182:1356.
    PubMed     Text format     Related articles   
    
    
    
51. GRAVAS S
    Editorial comment.
    J Urol. 2009;182:1335-6.
    PubMed     Text format     Related articles   
    
    
    
52. LIN CC
    Editorial comment.
    J Urol. 2009;182:1348.
    PubMed     Text format     Related articles   
    
    
    
53. VAN RENTERGHEM KM
    Editorial comment.
    J Urol. 2009;182:1349.
    PubMed     Text format     Related articles   
    
    
    
54. HAARER CF , Gopalan A, Tickoo SK, Scardino PT, et al
    Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
    J Urol. 2009;182:1337-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
55. CHENG T , Heng DY, Stewart D
    Re: Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troy
    J Urol. 2009.
    PubMed     Text format     Related articles   
    
    
    
56. SHARMA P , Wisniewski A, Braga-Basaria M, Xu X, et al
    Lack of an Effect of High Dose Isoflavones in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. DUFFIELD AS , Lee TK, Miyamoto H, Carter HB, et al
    Radical Prostatectomy Findings in Patients in Whom Active Surveillance of Prostate Cancer Fails.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. SONN GA , Sadetsky N, Presti JC, Litwin MS, et al
    Differing Perceptions of Quality of Life in Patients With Prostate Cancer and Their Doctors.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. SIMONATO A , Varca V, Esposito M, Venzano F, et al
    The Use of a Surgical Patch in the Prevention of Lymphoceles After Extraperitoneal Pelvic Lymphadenectomy for Prostate Cancer: A Randomized Prospective Pilot Study.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. GIRI VN , Coups EJ, Ruth K, Goplerud J, et al
    Prostate Cancer Early Detection Program Recruitment Methods and Show Rates in Men at High Risk.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. COLLI J
    Can Men Reduce the Risk of Prostate Cancer Through Lifestyle Changes?
    J Urol. 2009.
    PubMed     Text format     Related articles   
    
    
    
62. ROOBOL MJ , Schroder FH, Crawford ED, Freedland SJ, et al
    A Framework for the Identification of Men at Increased Risk for Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. ANTONELLI JA , Jones LW, Banez LL, Thomas JA, et al
    Exercise and Prostate Cancer Risk in a Cohort of Veterans Undergoing Prostate Needle Biopsy.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SUN L , Caire AA, Robertson CN, George DJ, et al
    Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. BELLINA M , Ambu A, Mari M
    Re: Is it necessary to remove the seminal vesicles completely at radical prostatectomy? Decision curve analysis of European Society of Urologic Oncology criteria F. P. Secin, F. J. Bianco, A. Cronin, J. A. Eastham, P. T. Scardino, B. Guillonneau and A. J
    J Urol. 2009;182:1233.
    PubMed     Text format     Related articles   
    
    
    
66. FROEHNER M , Koch R, Hakenberg OW, Wirth MP, et al
    Second cancers as competing causes of death after radical prostatectomy.
    J Urol. 2009;182:967-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. PETTUS JA , Masterson T, Sokol A, Cronin AM, et al
    Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy.
    J Urol. 2009;182:949-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. CADEDDU JA
    Editorial comment.
    J Urol. 2009;182:966.
    PubMed     Text format     Related articles   
    
    
    
69. DAHL DM , Barry MJ, McGovern FJ, Chang Y, et al
    A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy.
    J Urol. 2009;182:956-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. ELLIS RJ
    Editorial comment.
    J Urol. 2009;182:948.
    PubMed     Text format     Related articles   
    
    
    
71. CHIN JL
    Editorial comment.
    J Urol. 2009;182:937.
    PubMed     Text format     Related articles   
    
    
    
72. CHENG I
    Editorial comment.
    J Urol. 2009;182:971.
    PubMed     Text format     Related articles   
    
    
    
73. BANDER NH
    Editorial comment.
    J Urol. 2009;182:947-8.
    PubMed     Text format     Related articles   
    
    
    
74. LEVY DA , Pisters LL, Jones JS
    Primary cryoablation nadir prostate specific antigen and biochemical failure.
    J Urol. 2009;182:931-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SHAYEGAN B
    Editorial comment.
    J Urol. 2009;182:971.
    PubMed     Text format     Related articles   
    
    
    
76. DONNELLY B
    Editorial comment.
    J Urol. 2009;182:937.
    PubMed     Text format     Related articles   
    
    
    August 2009
77. FINLEY DS , Calvert VS, Inokuchi J, Lau A, et al
    Periprostatic Adipose Tissue as a Modulator of Prostate Cancer Aggressiveness.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. BEUTEN J , Garcia D, Brand TC, He X, et al
    Semaphorin 3B and 3F Single Nucleotide Polymorphisms are Associated With Prostate Cancer Risk and Poor Prognosis.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. BRIMO F , Vollmer RT, Bismar TA
    Re: The Number of Cores Positive for High Grade Prostatic Intraepithelial Neoplasia on Initial Biopsy is Associated With Prostate Cancer on Second Biopsy C. De Nunzio, A. Trucchi, R. Miano, A. Stoppacciaro, H. Fattahi, A. Cicione and A. TubaroJ Urol 2009
    J Urol. 2009.
    PubMed     Text format     Related articles   
    
    
    
80. CULIG Z
    New Insights Into the Role of Interleukin-6 in Human Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles   
    
    
    
81. HAM WS , Cho NH, Kim WT, Ju HJ, et al
    Pathological Effects of Prostate Cancer Correlate With Neuroendocrine Differentiation and PTEN Expression After Bicalutamide Monotherapy.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. STEPHENSON AJ , Wood DP, Kattan MW, Klein EA, et al
    Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. M C H DE LA ROSETTE JJ , Wink MH, Mamoulakis C, Wondergem N, et al
    Optimizing Prostate Cancer Detection: 8 Versus 12-Core Biopsy Protocol.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. LINDNER U , Weersink RA, Haider MA, Gertner MR, et al
    Image Guided Photothermal Focal Therapy for Localized Prostate Cancer: Phase I Trial.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. SMITH JA JR
    What would you do, doctor?
    J Urol. 2009;182:421-2.
    PubMed     Text format     Related articles   
    
    
    
86. BANEZ LL , Sun L, Trock BJ, Han M, et al
    Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    J Urol. 2009;182:491-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
87. BADEN J , Green G, Painter J, Curtin K, et al
    Multicenter Evaluation of an Investigational Prostate Cancer Methylation Assay.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. MOURAVIEV V , Madden JF, Broadwater G, Mayes JM, et al
    Use of (111)In-Capromab Pendetide Immunoscintigraphy to Image Localized Prostate Cancer Foci.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. BAHNSON R
    Adjunct Assays for Improving Prostate Cancer Detection.
    J Urol. 2009.
    PubMed     Text format     Related articles   
    
    
    
90. DELONGCHAMPS NB , Wang CY, Chandan V, Jones RF, et al
    Pathological Characteristics of Prostate Cancer in Elderly Men.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
91. YAQINUDDIN A , Qureshi SA, Qazi R, Farooq S, et al
    DNMT1 Silencing Affects Locus Specific DNA Methylation and Increases Prostate Cancer Derived PC3 Cell Invasiveness.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. BERGMAN J , Gore JL, Penson DF, Kwan L, et al
    Erectile Aid Use by Men Treated for Localized Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. POP GH , Fesperman SF, Ball DA, Yeung LL, et al
    Duplicate Presentations on Prostate Cancer at American Urological Association and European Association of Urology Annual Meetings.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. PISTERS LL , Leibovici D, Blute M, Zincke H, et al
    Locally Recurrent Prostate Cancer After Initial Radiation Therapy: A Comparison of Salvage Radical Prostatectomy Versus Cryotherapy.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. THOMPSON IM , Tangen CM, Goodman PJ, Lucia MS, et al
    Chemoprevention of Prostate Cancer.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. FIZAZI K , Bosserman L, Gao G, Skacel T, et al
    Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. MERRIMEN JL , Jones G, Walker D, Leung CS, et al
    Multifocal High Grade Prostatic Intraepithelial Neoplasia is a Significant Risk Factor for Prostatic Adenocarcinoma.
    J Urol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. MEEKS JJ , Loeb S, Helfand BT, Kan D, et al
    Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml.
    J Urol. 2009;181:2515-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
99. SIDDIQUI SA
    Obesity and Prostate Cancer: An Insight Into Postmodern Medicine.
    J Urol. 2009.
    PubMed     Text format     Related articles   
    
    
    
100. HEDGEPETH RC , Labo J, Zhang L, Wood DP Jr, et al
     Expanded Prostate Cancer Index Composite Versus Incontinence Symptom Index and Sexual Health Inventory for Men to Measure Functional Outcomes After Prostatectomy.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. LOEB S , Carter HB, Walsh PC, Isaacs WB, et al
     Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate Specific Antigen Level.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. DAVIES BJ , Smaldone MC, Sadetsky N, Dall'era M, et al
     The Impact of Obesity on Overall and Cancer Specific Survival in Men With Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. VAISHAMPAYAN UN , Marur S, Heilbrun LK, Cher ML, et al
     Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. GIBERTI C , Gallo F, Schenone M, Cortese P, et al
     The bone anchor suburethral synthetic sling for iatrogenic male incontinence: critical evaluation at a mean 3-year followup.
     J Urol. 2009;181:2204-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. FOWKE JH , Motley SS, Smith JA Jr, Cookson MS, et al
     Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.
     J Urol. 2009;181:2064-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. ANKERST DP , Miyamoto R, Nair PV, Pollock BH, et al
     Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population.
     J Urol. 2009;181:2071-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
107. YE L , Kynaston H, Jiang WG
     Bone Morphogenetic Protein-10 Suppresses the Growth and Aggressiveness of Prostate Cancer Cells Through a Smad Independent Pathway.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. PARK YH , Hwang IS, Jeong CW, Kim HH, et al
     Prostate Specific Antigen Half-Time and Prostate Specific Antigen Doubling Time as Predictors of Response to Androgen Deprivation Therapy for Metastatic Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. OUYANG B , Bracken B, Burke B, Chung E, et al
     A Duplex Quantitative Polymerase Chain Reaction Assay Based on Quantification of alpha-Methylacyl-CoA Racemase Transcripts and Prostate Cancer Antigen 3 in Urine Sediments Improved Diagnostic Accuracy for Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. HELFAND BT , Loeb S, Meeks JJ, Fought AJ, et al
     Pathological Outcomes Associated With the 17q Prostate Cancer Risk Variants.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. BLUTE ML
     No Proof of Inferiority: Open Radical Retropubic Prostatectomy Remains State-of-the-Art Surgical Technique for Localized Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles   
     
     
     
112. DROLLER MJ
     A guideline for discussion and some thoughts.
     J Urol. 2009;181:1530-1.
     PubMed     Text format     Related articles   
     
     
     
113. SCHAEFFER EM , Carter HB, Kettermann A, Loeb S, et al
     Prostate specific antigen testing among the elderly--when to stop?
     J Urol. 2009;181:1606-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. HIRATA H , Hinoda Y, Kikuno N, Suehiro Y, et al
     Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.
     J Urol. 2009;181:1907-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. FRANK SJ , Levy LB, Kuban DA, Lee AK, et al
     Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy.
     J Urol. 2009;181:1658-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. SHAPIRO EY , Rais-Bahrami S, Morgenstern C, Napolitano B, et al
     Long-term outcomes in younger men following permanent prostate brachytherapy.
     J Urol. 2009;181:1665-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. MARIOTTI G , Sciarra A, Gentilucci A, Salciccia S, et al
     Early recovery of urinary continence after radical prostatectomy using early pelvic floor electrical stimulation and biofeedback associated treatment.
     J Urol. 2009;181:1788-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. KONETY BR
     Prostate specific antigen screening and active surveillance in the elderly.
     J Urol. 2009;181:1534-5.
     PubMed     Text format     Related articles   
     
     
     March 2009
119. DOS REIS ST , Pontes J Jr, Villanova FE, Borra PM, et al
     Genetic Polymorphisms of Matrix Metalloproteinases: Susceptibility and Prognostic Implications for Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. GANS W
     Re: Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer R. J. Babaian, B. Donnelly, D. Bahn, J. G. Baust, M. Dineen, D. Ellis, A. Katz, L. Pisters, D. Rukstalis, K. Shinohara and J. B. ThrasherJ Urol 2008; 180: 1993-2004
     J Urol. 2009.
     PubMed     Text format     Related articles   
     
     
     
121. ATMACA AF , Balbay MD
     Re: The Performance of Prostate Specific Antigen for Predicting Prostate Cancer is Maintained After a Prior Negative Prostate Biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 200
     J Urol. 2009.
     PubMed     Text format     Related articles   
     
     
     
122. SAYLOR PJ , Smith MR
     Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. BREYER BN , Whitson JM, Freise CE, Meng MV, et al
     Prostate Cancer Screening and Treatment in the Transplant Population: Current Status and Recommendations.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. BERGMAN J , Kwan L, Fink A, Connor SE, et al
     Hospice and Emergency Room Use by Disadvantaged Men Dying of Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. CHING CB , Moussa AS, Li J, Lane BR, et al
     Does Transrectal Ultrasound Probe Configuration Really Matter? End Fire Versus Side Fire Probe Prostate Cancer Detection Rates.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. SCHOUT BM , Bemelmans BL, Martens EJ, Scherpbier AJ, et al
     How useful and realistic is the uro trainer for training transurethral prostate and bladder tumor resection procedures?
     J Urol. 2009;181:1297-303.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. TAREEN B , Godoy G, Sankin A, Temkin S, et al
     Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.
     J Urol. 2009;181:1082-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
128. FELDSTEIN MS , Hentz JG
     Re: Risk of Prostate Cancer After Diagnosis of Atypical Glands Suspicious for Carcinoma on Saturation and Traditional Biopsies R. Abouassaly, N. Tan, A. Moussa and J. S. JonesJ Urol 2008; 180: 911-914.
     J Urol. 2009.
     PubMed     Text format     Related articles   
     
     
     
129. KRAMER BS , Hagerty KL, Justman S, Somerfield MR, et al
     Use of 5alpha-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. KJELLMAN A , Akre O, Norming U, Tornblom M, et al
     15-Year Followup of a Population Based Prostate Cancer Screening Study.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. EGGENER SE , Mueller A, Berglund RK, Ayyathurai R, et al
     A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. WEISS G , Cottrell S, Distler J, Schatz P, et al
     DNA Methylation of the PITX2 Gene Promoter Region is a Strong Independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. CONTI SL , Dall'era M, Fradet V, Cowan JE, et al
     Pathological Outcomes Meeting Criteria for Active Surveillance of Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. DALL'ERA MA , Hosang N, Konety B, Cowan JE, et al
     Sociodemographic Predictors of Prostate Cancer Risk Category at Diagnosis: Unique Patterns of Significant and Insignificant Disease.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. MONONEN N , Schleutker J
     Polymorphisms in Genes Involved in Androgen Pathways as Risk Factors for Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. SHEPARD DR , Dreicer R, Garcia J, Elson P, et al
     Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. UMAR SA , Umar SA, MacLennan GT
     Small cell carcinoma of the prostate.
     J Urol. 2009;181:838-9.
     PubMed     Text format     Related articles   
     
     
     
138. GALOSI AB , Montironi R, Fabiani A, Lacetera V, et al
     Cystic lesions of the prostate gland: an ultrasound classification with pathological correlation.
     J Urol. 2009;181:647-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. GLICKMAN L , Godoy G, Lepor H
     Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
     J Urol. 2009;181:731-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. MULHALL JP
     Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions.
     J Urol. 2009;181:462-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. GIANNARINI G , Autorino R, Valent F, Mogorovich A, et al
     Combination of perianal-intrarectal lidocaine-prilocaine cream and periprostatic nerve block for pain control during transrectal ultrasound guided prostate biopsy: a randomized, controlled trial.
     J Urol. 2009;181:585-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. SECIN FP , Bianco FJ, Cronin A, Eastham JA, et al
     Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.
     J Urol. 2009;181:609-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
143. FIGG WD , Hussain MH, Gulley JL, Arlen PM, et al
     A Double-Blind Randomized Crossover Study of Oral Thalidomide Versus Placebo for Androgen Dependent Prostate Cancer Treated With Intermittent Androgen Ablation.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. THOMPSON IM , Tangen CM, Paradelo J, Lucia MS, et al
     Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. BEN-YOSEF R , Paz A, Levy Y, Alani S, et al
     A Novel Device for Protecting Rectum During Prostate Cancer Irradiation: In Vivo Data on a Large Mammal Model.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. ROSENZWEIG CN , Zhang Z, Sun X, Sokoll LJ, et al
     Predicting Prostate Cancer Biochemical Recurrence Using a Panel of Serum Proteomic Biomarkers.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. MILANESE G , Dellabella M, Fazioli F, Pierpaoli E, et al
     Increased Urokinase-Type Plasminogen Activator Receptor and Epidermal Growth Factor Receptor in Serum of Patients With Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. WALSH PC
     Re: It's Time to Abandon an Upper Limit of Normal for Prostate Specific Antigen: Assessing the Risk of Prostate Cancer I. M. Thompson, D. P. Ankerst, R. Etzioni and T. WangJ Urol 2008; 180: 1219-1222.
     J Urol. 2009.
     PubMed     Text format     Related articles   
     
     
     
149. ROSSI PJ , Johnstone PA
     Devices for Protecting the Rectum During Radiation Therapy of Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles   
     
     
     
150. MORGENTALER A
     Testosterone Therapy in Men With Prostate Cancer: Scientific and Ethical Considerations.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. DE NUNZIO C , Trucchi A, Miano R, Stoppacciaro A, et al
     The Number of Cores Positive for High Grade Prostatic Intraepithelial Neoplasia on Initial Biopsy is Associated With Prostate Cancer on Second Biopsy.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. SCHWENKE C , Ubrig B, Thurmann P, Eggersmann C, et al
     Lycopene for Advanced Hormone Refractory Prostate Cancer: A Prospective, Open Phase II Pilot Study.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. OKEGAWA T , Nutahara K, Higashihara E
     Prognostic Significance of Circulating Tumor Cells in Patients With Hormone Refractory Prostate Cancer.
     J Urol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. MEARINI L , D'Urso L, Collura D, Zucchi A, et al
     Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the italian experience.
     J Urol. 2009;181:105-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. BOYD CN
     Re: Prostate specific antigen working group guidelines on prostate specific antigen doubling time: P. M. Arlen, F. Bianco, W. L. Dahut, A. D'Amico, W. D. Figg, s. J. Freedland, J. L. Gulley, P. W. Kantoff, M. W. Kattan, A. Lee, M. M. Regan and O. Sartor
     J Urol. 2009;181:411.
     PubMed     Text format     Related articles   
     
     
     
156. BOORJIAN SA , Karnes RJ, Crispen PL, Rangel LJ, et al
     The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.
     J Urol. 2009;181:95-104.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. BALTACI S , Suer E, Haliloglu AH, Gokce MI, et al
     Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen.
     J Urol. 2009;181:128-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. CHEN AB , D'Amico AV, Neville BA, Steyerberg EW, et al
     Provider case volume and outcomes following prostate brachytherapy.
     J Urol. 2009;181:113-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
159. MILLER DC , Litwin MS, Bergman J, Stepanian S, et al
     Prostate Cancer Severity Among Low Income, Uninsured Men.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. YE H , Li Y, Melamed J, Pearce P, et al
     Stromal Anti-Apoptotic Androgen Receptor Target Gene c-FLIP in Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. OLIVER MN
     Access to Prostate Cancer Care and Implications for Survival Among Minorities.
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
162. SHAH SK , Trump DL, Sartor O, Tan W, et al
     Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. BASS R , Perry B, Langenstroer P, Thrasher JB, et al
     Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. WALZ J , Chun FK, Klein EA, Reuther A, et al
     Nomogram Predicting the Probability of Early Recurrence After Radical Prostatectomy for Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. ANTUNES AA , Leite KR, Sousa-Canavez JM, Camara-Lopes LH, et al
     The Role of Prostate Specific Membrane Antigen and Pepsinogen C Tissue Expression as an Adjunctive Method to Prostate Cancer Diagnosis.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. PRUTHI RS , Swords K, Schultz H, Carson CC 3rd, et al
     The Impact of Obesity on the Diagnosis of Prostate Cancer Using a Modern Extended Biopsy Scheme.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. SIVANANDAM A , Bhandari M
     Re: Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories: E. A. Klein, F. J. Bianco, A. M. Serio, J. A. Eastham, M. W. Kattan, J. E. Pontes, A. J. Vickers and P. T. Scardin
     J Urol. 2008;180:2716-7.
     PubMed     Text format     Related articles   
     
     
     
168. MAI KT , Veinot JP
     Re: Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features: R. J. Cohen, B. A. Shannon, M. Phillips, R. E. Moorin, T. M. Wheeler and K. L. Garrett J Urol 2008; 179: 1762-1767.
     J Urol. 2008;180:2714.
     PubMed     Text format     Related articles   
     
     
     
169. ATMACA AF
     Re: Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006: M. Musch, V. Klevecka, U. Roggenbuck and D. Kroepfl J Urol 2008; 179: 923-929.
     J Urol. 2008;180:2715.
     PubMed     Text format     Related articles   
     
     
     
170. NAKANISHI H , Troncoso P, Babaian RJ
     Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater.
     J Urol. 2008;180:2441-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. SWANSON GP , Goldman B, Tangen CM, Chin J, et al
     The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794.
     J Urol. 2008;180:2453-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. GONZALEZ JR , Consedine NS, McKiernan JM, Spencer BA, et al
     Barriers to the initiation and maintenance of prostate specific antigen screening in Black American and Afro-Caribbean men.
     J Urol. 2008;180:2403-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. WHITE WM , Sadetsky N, Waters WB, Carroll PR, et al
     Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database.
     J Urol. 2008;180:2409-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
174. HAGA K , Tomioka A, Liao CP, Kimura T, et al
     PTEN Knockout Prostate Cancer as a Model for Experimental Immunotherapy.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. SCHOSTAK M , Schwall GP, Poznanovic S, Groebe K, et al
     Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. KONETY BR
     Panning for Prostate Gold: Urine Based Markers for Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
177. NGUYEN CT , Reuther AM, Stephenson AJ, Klein EA, et al
     The Specific Definition of High Risk Prostate Cancer Has Minimal Impact on Biochemical Relapse-Free Survival.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. VENKATARAMAN G , Rycyna K, Rabanser A, Heinze G, et al
     Morphometric Signature Differences in Nuclei of Gleason Pattern 4 Areas in Gleason 7 Prostate Cancer With Differing Primary Grades on Needle Biopsy.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. SCHRODER FH , Roobol MJ, Andriole GL, Fleshner N, et al
     Defining Increased Future Risk for Prostate Cancer: Evidence From a Population Based Screening Cohort.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. MATHEW P , Pisters LL, Wood CG, Papadopoulos JN, et al
     Neoadjuvant Platelet Derived Growth Factor Receptor Inhibitor Therapy Combined With Docetaxel and Androgen Ablation for High Risk Localized Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. MASIERI L , Minervini A, Serni S, Carini M, et al
     Re: A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy: J. A. Smith, Jr., R. C. Chan, S. S. Chang, S. D. Herrell, P. E. Clark, R. Baumga
     J Urol. 2008;180:2257.
     PubMed     Text format     Related articles   
     
     
     
182. SEREFOGLU EC , Ozdemir AT, Balbay MD
     Re: The 20-core prostate biopsy protocol--a new gold standard?: V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod and L. Boccon-Gibod. J Urol 2008; 179: 504-507.
     J Urol. 2008;180:2256-7.
     PubMed     Text format     Related articles   
     
     
     
183. WHITMAN EJ , Groskopf J, Ali A, Chen Y, et al
     PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
     J Urol. 2008;180:1975-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. KUO NW , Lin HC, Lee HC
     Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
     J Urol. 2008;180:1954-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. LOEB S , Chan DW, Sokoll L, Kan D, et al
     Prostate specific antigen assay standardization bias could affect clinical decision making.
     J Urol. 2008;180:1959-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. TEETER AE , Banez LL, Presti JC Jr, Aronson WJ, et al
     What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
     J Urol. 2008;180:1980-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. BERGLUND RK , Masterson TA, Vora KC, Eggener SE, et al
     Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.
     J Urol. 2008;180:1964-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. HU JC , Hevelone ND, Ferreira MD, Lipsitz SR, et al
     Patterns of care for radical prostatectomy in the United States from 2003 to 2005.
     J Urol. 2008;180:1969-74.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
189. RUBINSKY J , Onik G, Mikus P, Rubinsky B, et al
     Optimal Parameters for the Destruction of Prostate Cancer Using Irreversible Electroporation.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. LEE GT , Hong JH, Mueller TJ, Watson JA, et al
     Effect of IN-1130, a Small Molecule Inhibitor of Transforming Growth Factor-beta Type I Receptor/Activin Receptor-Like Kinase-5, on Prostate Cancer Cells.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. HOLT SK , Salinas CA, Stanford JL
     Vasectomy and the Risk of Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. SIMONE NL , Singh AK, Cowan JE, Soule BP, et al
     Pretreatment Predictors of Death From Other Causes in Men With Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. THONG AE , Shikanov S, Katz MH, Gofrit ON, et al
     A Single Microfocus (5% or Less) of Gleason 6 Prostate Cancer at Biopsy-Can We Predict Adverse Pathological Outcomes?
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. STATTIN P , Holmberg E, Bratt O, Adolfsson J, et al
     Surveillance and Deferred Treatment for Localized Prostate Cancer. Population Based Study in the National Prostate Cancer Register of Sweden.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. WU AK , Cooperberg MR, Sadetsky N, Carroll PR, et al
     Health Related Quality of Life in Patients Treated With Multimodal Therapy for Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. MOUL JW
     Are We Overtreating Prostate Cancer?
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
197. VAN PATTEN CL , de Boer JS, Tomlinson Guns ES
     Diet and Dietary Supplement Intervention Trials for the Prevention of Prostate Cancer Recurrence: A Review of the Randomized Controlled Trial Evidence.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. GOEL MC
     Re: Robotic simple prostatectomy R. Sotelo, R. Clavijo, O. Carmona, A. Garcia, E. Banda, M. Miranda and R. Fagin J Urol 2008; 179: 513-515.
     J Urol. 2008;180:1569-70.
     PubMed     Text format     Related articles   
     
     
     
199. NG CF , Chan SY
     Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
     J Urol. 2008;180:1570-1.
     PubMed     Text format     Related articles   
     
     
     
200. SALMASI AH , Wisniewski AB, Novak TE, Gearhart JP, et al
     Prostate screening in patients with 46,XY disorders of sex development--is it necessary?
     J Urol. 2008;180:1422-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. BAROCAS DA , Cowan JE, Smith JA Jr, Carroll PR, et al
     What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
     J Urol. 2008;180:1330-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. ELLIOTT CS , Shinghal R, Presti JC Jr
     Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes.
     J Urol. 2008;180:1318-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. TAN N , Lane BR, Li J, Moussa AS, et al
     Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
     J Urol. 2008;180:1325-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
204. BABAIAN CHAIR RJ , Donnelly Facilitator B, Bahn D, Baust JG, et al
     Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
205. PEEHL DM , Coram M, Khine H, Reese S, et al
     The Significance of Monoamine Oxidase-A Expression in High Grade Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. COQUARD R
     Re: Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate Cancer M. J. Zelefsky, V. E. Reuter, Z. Fuks, P. Scardino and A. ShippyJ Urol 2008; 179: 1368-1373.
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
207. SONG C , Ahn H, Lee MS, Park J, et al
     Mass Screening for Prostate Cancer in Korea: A Population Based Study.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. NIEDER AM , Porter MP, Soloway MS
     Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. URBA WJ , Nemunaitis J, Marshall F, Smith DC, et al
     Treatment of Biochemical Recurrence of Prostate Cancer With Granulocyte-Macrophage Colony-Stimulating Factor Secreting, Allogeneic, Cellular Immunotherapy.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. GITTELMAN M , Pommerville PJ, Persson BE, Jensen JK, et al
     A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for in the Treatment of Prostate Cancer in North America.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. AUS G
     Cryosurgery for Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
212. THOMAS C , Wiesner C, Melchior S, Gillitzer R, et al
     Indications for Preoperative Prostate Biopsy in Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. PRAKASH G , Gagan G
     Re: Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. R. A. Linden, E. J. Trabulsi, F. Forsberg, P. R. Gittens, L. G. Gomella and E. J. Halpern. J Urol 2007; 178: 2354-2358.
     J Urol. 2008;180:1184.
     PubMed     Text format     Related articles   
     
     
     
214. MENON M , Muhletaler F, Campos M, Peabody JO, et al
     Assessment of early continence after reconstruction of the periprostatic tissues in patients undergoing computer assisted (robotic) prostatectomy: results of a 2 group parallel randomized controlled trial.
     J Urol. 2008;180:1018-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. WILT TJ , Shamliyan TA, Taylor BC, MacDonald R, et al
     Association between hospital and surgeon radical prostatectomy volume and patient outcomes: a systematic review.
     J Urol. 2008;180:820-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. KARAKIEWICZ PI , Bhojani N, Capitanio U, Reuther AM, et al
     External validation of the updated Partin tables in a cohort of North American men.
     J Urol. 2008;180:898-902.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. LINK BA , Nelson R, Josephson DY, Yoshida JS, et al
     The impact of prostate gland weight in robot assisted laparoscopic radical prostatectomy.
     J Urol. 2008;180:928-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
218. FERNANDO HS , Sanders AJ, Kynaston HG, Jiang WG, et al
     WAVE1 is Associated With Invasiveness and Growth of Prostate Cancer Cells.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. GULLEY JL , Aragon-Ching JB, Steinberg SM, Hussain MH, et al
     Kinetics of Serum Androgen Normalization and Factors Associated With Testosterone Reserve After Limited Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. YOON FH , Gardner SL, Danjoux C, Morton G, et al
     Testosterone Recovery After Prolonged Androgen Suppression in Patients With Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. ANKERST DP , Groskopf J, Day JR, Blase A, et al
     Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. NEAL DE
     Can We Accurately Identify Men With Low Risk Prostate Cancer?
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
223. THOMPSON IM , Ankerst DP, Etzioni R, Wang T, et al
     It's Time to Abandon an Upper Limit of Normal for Prostate Specific Antigen: Assessing the Risk of Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles   
     
     
     
224. OKEGAWA T , Nutahara K, Higashihara E
     Immunomagnetic Quantification of Circulating Tumor Cells as a Prognostic Factor of Androgen Deprivation Responsiveness in Patients With Hormone Naive Metastatic Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. ERCOLE B , Marietti SR, Fine J, Albertsen PC, et al
     Outcomes Following Active Surveillance of Men With Localized Prostate Cancer Diagnosed in the Prostate Specific Antigen Era.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. MULLER H , Haug U, Rothenbacher D, Stegmaier C, et al
     Evaluation of Serum and Urinary Myeloid Related Protein-14 as a Marker for Early Detection of Prostate Cancer.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. PISTERS LL , Rewcastle JC, Donnelly BJ, Lugnani FM, et al
     Salvage prostate cryoablation: initial results from the cryo on-line data registry.
     J Urol. 2008;180:559-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. RAMPERSAUD EN , Sun L, Moul JW, Madden J, et al
     Percent tumor involvement and risk of biochemical progression after radical prostatectomy.
     J Urol. 2008;180:571-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. AHMED FS , Borrell LN, Spencer BA
     Health risk behaviors and prostate specific antigen awareness among men in California.
     J Urol. 2008;180:658-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
230. SHIKANOV SA , Eng MK, Bernstein AJ, Katz M, et al
     Urinary and sexual quality of life 1 year following robotic assisted laparoscopic radical prostatectomy.
     J Urol. 2008;180:663-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. REED AB , Ankerst DP, Leach RJ, Vipraio G, et al
     Total prostate specific antigen stability confirmed after long-term storage of serum at -80C.
     J Urol. 2008;180:534-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. JONES JS , Rewcastle JC, Donnelly BJ, Lugnani FM, et al
     Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
     J Urol. 2008;180:554-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. BILLIS A , Guimaraes MS, Freitas LL, Meirelles L, et al
     The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
     J Urol. 2008;180:548-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
234. ROUDIER MP , Morrissey C, True LD, Higano CS, et al
     Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases.
     J Urol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
235. CANES D
     Re: A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J. A. Smith, Jr., R. C. Chan, S. S. Chang, S. D. Herrell, P. E. Clark, R. Baumga
     J Urol. 2008;180:410-1.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: